Nova Eye Medical Limited
ELXMF
$0.10
-$0.086-46.24%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.65M | -5.72M | -5.76M | -7.62M | -9.55M |
| Total Depreciation and Amortization | 1.40M | 1.40M | 1.39M | 1.27M | 1.16M |
| Total Amortization of Deferred Charges | 393.20K | 483.10K | 569.00K | 569.00K | 569.00K |
| Total Other Non-Cash Items | 328.90K | 122.40K | -90.30K | 1.66M | 3.45M |
| Change in Net Operating Assets | -1.30M | -1.30M | -1.30M | -583.60K | 129.10K |
| Cash from Operations | -4.82M | -5.02M | -5.18M | -4.70M | -4.24M |
| Capital Expenditure | -72.70K | -105.60K | -137.90K | -191.10K | -245.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.50K | -19.60K | -41.50K | -57.00K | -72.40K |
| Cash from Investing | -70.10K | -125.20K | -179.50K | -248.20K | -318.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -536.00K | -527.00K | -518.00K | -608.50K | -699.00K |
| Issuance of Common Stock | 7.43M | 7.43M | 7.43M | 7.45M | 7.47M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.54M | 4.54M | 4.55M | 4.54M | 4.58M |
| Foreign Exchange rate Adjustments | 114.40K | 58.70K | 1.40K | 34.10K | 67.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -242.80K | -540.80K | -810.50K | -378.80K | 92.40K |